Genetic Research Institute of the Desert, Logo
Phone Icon (760) 346-4151


Cancers

Breast Cancer  |  Melanoma  |  Prostate Cancer


References


Comings DE, Gade-Andavolu R, Cone LA, Muhleman D, MacMurray JP: A multigene test for the risk of sporadic breast carcinoma. Cancer 2003 May 1; 97(9): 2160-70.

Gade-Andavolu R, Cone LA, Shu S, Schulz K: Identification of Breast Cancer Risk Predicting Genes. AACR Oncogenomics : Dissecting Cancer through Genome Research, Feb 2-6,2005, San Diego, CA, C-36.

Gade Andavolu R, Cone LA, Shu S. Association of KLF6 gene polymorphism with hormone dependent cancers. AACR Drugging the Cancer Genome: Developing Rational combination therapies for multigene cancers. Jan 25-29,2006 P-3.Rancho Mirage, CA.  

Gade-Andavolu, R, Cone LA, Shu S, Andavolu MVS.Genetic polymorphisms in proinflammatory genes and risk of breast cancer. San Antonio Texas Breast cancer symposium, Dec14-17, 2006.

Gade-Andavolu R; Cone LA, Shu S; Morrow A, Kowshik B, Andavolu,MVS: Molecular Interactions of Leptin Prostate Cancer. The Cancer Journal, Volume 12, Number 3, May/June 2006 201-206(6 pp).

Gade Andavolu R, Cone LA, Shu S, Vuppala V, Andavolu MVS: Gene variants and their strong association with breast cancer. AACR Molecular target in Cancer Therapeutics International Conference, Oct 22-26, 2007, San Francisco, CA.

Gade-Andavolu, R, Cone, LA, Rubakovic S, Guss J, Shu S, Andavolu, MVS: New gene associations and risk of Melanoma.5th International Sumposium on Melanoma and other cutaneous Malignancies, New York. March 7-8, 2008.

Gade Andavolu R, Frisman D, Cone LA, Shu S, Andavolu MVS: Gene expression profiling in Prostate cancer. AACR Annaul Meeting, San Diego, April12-16, 2008 Proceedings AACR section 8, P# 4421.

Gade-Andavolu R, Frisman D, Rodriguez A, Shu S, Andavolu MVS: Oligo GEArray®: Validation of gene expression data by Real-Time™ qPCR and immunohistochemistry. AACR Molecular Targets in Cancer Therapeutics International Conference, Nov 15-19, 2009, Boston, MA.

Gade-Andavolu R, Rubakovic S, Shu S, MacMurray J. CDKN2A (p16) gene interaction with BCCIP alpha (TOK-1A) in Melanoma. SMR-7th international Melanoma Congress. Australia. Nov 4-7th.2010.

Gade-Andavolu R, Shu S, Andavolu M, Rubakovic S, MacMurray J. Tumor necrosis factor and CCR5 gene associations with cancer risk. EORTC-AACR-NCI International Conference,Berlin Germany.Nov 16-19th,2010 #115.

Gade-Andavolu R, Rubkovic S, Rubin J, Bir J, Shu S, Andavolu M, MacMurray J: Association of p53codon polymorphism, BCCIP & CDKN2A with Melanoma risk. A p53-dependent mechanism. AACR ANNUAL MEETING MARCH 31ST – APRIL 4TH, 2012, CHICAGO. IL. P#2651.

Gade-Andavolu R, Rubakovic S, Shu s, Bir J, Rubin J, Reddy NV, Mac Murray J: Acid Phosphatase Gene polymorphism (ACP1) as a new risk marker for malignant melanoma. The Society for Melanoma Research. Nov8-11th, 2012 Congress Hollywood California. Pigment cell and melanoma research suppl.Nov.2012.

Gade-Andavolu R, Mac Murray J, Andavolu MVS, Cardenas J-L,Bir J, Reddy NV, Shu S, Rubakovic S: Interaction of TNF-alpha and BCCIP gene polymorphisms in Increased Prostate cancer Risk. Ninth AACR JCA Joint Conference: Breakthroughs in Basic & Translational Cancer research, Feb 21-25, 2013.


Gade-Andavolu, Cardenas J-L, Shore R, Rubin Z, MacMurray J, K Chiravuri K, Andavolu MVS, Rubakovic S. Association of genetic variants with prostate cancer risk AACR Annual Meeting 2013. April 6, p#1932.

Torabi S, Gade-Andavolu R Murthy VS Andavolu. CDKN2A polymorphisms and the risk of developing sex-specific cancers Under Graduate Student Caucas Poster Competition AACR Annual Meeting 2014.


Jacob R, Gade Andavolu R, Go H-V, Rubakovic S. TGF-α Gene Polymorphism and Melanoma Cancer Risk. AACR under-Graduate student Caucas Poster competition, 2015, Philadelphia, PA.


Torabi SJ, Gade-Andavolu R, Rubakovic A, Andavolu MVS. CDKN2A Polymorphisms, Gender, & Cancer Risk. AACR Under-Graduate Student Caucas Poster Competition, 2015, Philadelphia, PA.


Andavolu RG, Stafford C, Andavolu MV, Cardenas J-L, Rubin J, Shore R, Rubakovic S. NF-kB -p53 gene associations and prostate cancer risk. AACR ANNUAL MEETING 2015. April 18-22, 2015 • Philadelphia, PA. Proceedings Section: #4841 - Identification of Molecular Markers.


Gade-Andavolu R, Napolioni V, MacMurray J, Andavolu MVS, Cardenas J-L, Rubakovic S, Bir JS, Shore  R, Rubin  J, Chiravuri K, Torabi S, Reddy NV, Shu S, Klitgaard E, Comings : Interaction Between TNFα and BCCIPα Polymorphisms is Associated with Breast Cancer Susceptibility. Cancer Biomarkers (submitted).


Gade-Andavolu R, Rubakovic S, Stafford C, Torabi.S, Rubin J, Shore R, Cardenas J-L: Association of Acid Phosphatase Gene polymorphism (ACP1) Haplotypes with malignant melanoma.(2015) (Submitted).